Janet Hildebrand is an epidemiologist specializing in chronic diseases including cancer, diabetes, obesity, and other conditions. Prior to joining Target RWE, Janet worked in the private nonprofit sector and academia leveraging large cohort databases and consortia to study exposures such as hormone therapy in women, obesity, physical activity, and sedentary behavior, in relation to cancer and allcause mortality. Her work is published in The Lancet, American Journal of Preventive Medicine, American Journal of Epidemiology, Cancer Epidemiology Biomarkers and Prevention, International Journal of Cancer, PLoS One, Gastroenterology, and more. At Target RWE, Janet collaborates on studies of immune-mediated conditions such as inflammatory bowel disease. A list of Janet’s publications can be found at: scholar.google.com/citations?user=4M5ssIkAAAAJ&hl=en&oi=ao.
Janet’s decision to pursue a career in research was partly motivated by her father’s cancer journey. “Getting a diagnosis of any serious chronic condition is life-altering. I am passionate about purposeful, mission-driven research that has potential to save lives and improve the quality of life for people living with life-threatening and difficult-to-treat diseases.” Janet received her master’s degree in Epidemiology from Emory University and is nearing completion of the PhD in Health Services Research at the Medical University of South Carolina.